MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling have?
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling has 434 citations in the OpenAlex counts ScholarIQ stores.
When was MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling published?
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling has 2012 year in the ScholarIQ index.
What is the open-access status of MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling?
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling has bronze oa status in the ScholarIQ index.
What is the DOI of MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling?
The DOI for MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling is on the source record.
What is the PMID of MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling?
The PMID for MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling is on the source record.
What is the OpenAlex record for MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling?
The OpenAlex for MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling is on the source record.